Ray Dalio's CORT Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 279,000 shares of Corcept Therapeutics Incorporated (CORT) worth $9.71 M, representing 0.04% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in CORT, representing a fresh investment thesis on this company. Largest reduction occurred in Q4 2025, reducing 26,946 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Corcept Therapeutics Incorporated (CORT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Corcept Therapeutics Incorporated (CORT) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -26,946 | Reduce 8.81% | 279,000 | $34.80 |
| Q3 2025 | +305,946 | New Buy | 305,946 | $83.11 |
Ray Dalio's Corcept Therapeutics Incorporated Investment FAQs
Ray Dalio first purchased Corcept Therapeutics Incorporated (CORT) in Q3 2025, acquiring 305,946 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Corcept Therapeutics Incorporated (CORT) for 2 quarters since Q3 2025.
Ray Dalio's largest addition to Corcept Therapeutics Incorporated (CORT) was in Q3 2025, adding 305,946 shares worth $25.43 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 279,000 shares of Corcept Therapeutics Incorporated (CORT), valued at approximately $9.71 M.
As of the Q4 2025 filing, Corcept Therapeutics Incorporated (CORT) represents approximately 0.04% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Corcept Therapeutics Incorporated (CORT) was 305,946 shares, as reported at the end of Q3 2025.